Koji Arata

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study

K. Suzuki, Takeharu Yamanaka, Hiroki Hashimoto et al. · Annals of Oncology · 2016 · 97 citations · Full text

Medicine, Oncology, Pharmacology +16

The lactate clearance calculated using serum lactate level 6 h after is an important prognostic predictor after extracorporeal cardiopulmonary resuscitation: a single-center retrospective observational study

Takashi Mizutani, Norio Umemoto, Toshio Taniguchi et al. · Journal of Intensive Care · 2018 · 30 citations · Full text

Medicine, Cardiology, Cardiopulmonary Rehabilitation +14

“Peninsula-Style” Transverse Aortic Arch Replacement in Patients With Bicuspid Aortic Valve

Akinobu Itoh, Michael P. Fischbein, Koji Arata et al. · The Annals of Thoracic Surgery · 2010 · 18 citations · Full text

Medicine, Cardiology, Surgery +11

Palonosetron (PALO) versus granisetron (GRA) in the triplet regimen with dexamethasone (DEX) and aprepitant (APR) for preventing chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving highly emetogenic chemotherapy (HEC) with cisplatin (CDDP): A randomized, double-blind, phase III trial.

Hironobu Hashimoto, Takeharu Yamanaka, Yasuhiro Shimada et al. · Journal of Clinical Oncology · 2013 · 17 citations

Medicine, Oncology, Pharmacology +13

Characterization of mitral valve anterior leaflet perfusion patterns.

Julia C. Swanson, Lauren R. Davis, Koji Arata et al. · PubMed · 2009 · 13 citations

Medicine, Anatomy, Cardiology +9